Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 3
2005 1
2006 2
2007 1
2010 1
2011 4
2012 1
2013 1
2014 2
2015 3
2016 1
2017 1
2019 3
2020 5
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
NK Cell-Based Immunotherapy in Colorectal Cancer.
Della Chiesa M, Setti C, Giordano C, Obino V, Greppi M, Pesce S, Marcenaro E, Rutigliani M, Provinciali N, Paleari L, DeCensi A, Sivori S, Carlomagno S. Della Chiesa M, et al. Among authors: carlomagno s. Vaccines (Basel). 2022 Jun 28;10(7):1033. doi: 10.3390/vaccines10071033. Vaccines (Basel). 2022. PMID: 35891197 Free PMC article. Review.
CD19-Targeted Immunotherapies for Diffuse Large B-Cell Lymphoma.
Gambella M, Carlomagno S, Raiola AM, Giannoni L, Ghiggi C, Setti C, Giordano C, Luchetti S, Serio A, Bo A, Falco M, Della Chiesa M, Angelucci E, Sivori S. Gambella M, et al. Among authors: carlomagno s. Front Immunol. 2022 Feb 24;13:837457. doi: 10.3389/fimmu.2022.837457. eCollection 2022. Front Immunol. 2022. PMID: 35280988 Free PMC article. Review.
NK Cell-Based Immunotherapy for Hematological Malignancies.
Sivori S, Meazza R, Quintarelli C, Carlomagno S, Della Chiesa M, Falco M, Moretta L, Locatelli F, Pende D. Sivori S, et al. Among authors: carlomagno s. J Clin Med. 2019 Oct 16;8(10):1702. doi: 10.3390/jcm8101702. J Clin Med. 2019. PMID: 31623224 Free PMC article. Review.
NK/DC crosstalk in anti-viral response.
Marcenaro E, Carlomagno S, Pesce S, Moretta A, Sivori S. Marcenaro E, et al. Among authors: carlomagno s. Adv Exp Med Biol. 2012;946:295-308. doi: 10.1007/978-1-4614-0106-3_17. Adv Exp Med Biol. 2012. PMID: 21948375 Review.
TLR/NCR/KIR: Which One to Use and When?
Sivori S, Carlomagno S, Pesce S, Moretta A, Vitale M, Marcenaro E. Sivori S, et al. Among authors: carlomagno s. Front Immunol. 2014 Mar 19;5:105. doi: 10.3389/fimmu.2014.00105. eCollection 2014. Front Immunol. 2014. PMID: 24678311 Free PMC article. Review.
Human NK cell response to pathogens.
Della Chiesa M, Marcenaro E, Sivori S, Carlomagno S, Pesce S, Moretta A. Della Chiesa M, et al. Among authors: carlomagno s. Semin Immunol. 2014 Apr;26(2):152-60. doi: 10.1016/j.smim.2014.02.001. Epub 2014 Feb 28. Semin Immunol. 2014. PMID: 24582551 Review.
miRNAs in NK Cell-Based Immune Responses and Cancer Immunotherapy.
Pesce S, Greppi M, Ferretti E, Obino V, Carlomagno S, Rutigliani M, Thoren FB, Sivori S, Castagnola P, Candiani S, Marcenaro E. Pesce S, et al. Among authors: carlomagno s. Front Cell Dev Biol. 2020 Feb 25;8:119. doi: 10.3389/fcell.2020.00119. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32161759 Free PMC article. Review.
Features of Memory-Like and PD-1(+) Human NK Cell Subsets.
Della Chiesa M, Pesce S, Muccio L, Carlomagno S, Sivori S, Moretta A, Marcenaro E. Della Chiesa M, et al. Among authors: carlomagno s. Front Immunol. 2016 Sep 14;7:351. doi: 10.3389/fimmu.2016.00351. eCollection 2016. Front Immunol. 2016. PMID: 27683578 Free PMC article. Review.
35 results